ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,604,217 | +13.9% | 230,491 | -12.7% | 0.08% | -9.5% |
| Q3 2022 | $1,409,000 | +123.3% | 263,924 | +67.0% | 0.08% | +180.0% |
| Q2 2022 | $631,000 | -10.1% | 158,031 | 0.0% | 0.03% | +7.1% |
| Q1 2022 | $702,000 | +8.2% | 158,031 | -2.5% | 0.03% | +21.7% |
| Q4 2021 | $649,000 | +15.9% | 162,134 | +154.2% | 0.02% | +27.8% |
| Q3 2021 | $560,000 | – | 63,786 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
| Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
| Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
| Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
| Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
| APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
| JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
| Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |